Impaired glucose metabolism predicts mortality after a myocardial infarction
Introduction
Cardiovascular disease is a well-known complication of non-insulin dependent diabetes and a major cause of morbidity and mortality in diabetic patients [1], [2], [3]. Once coronary heart disease has been established the mortality rate of diabetic patients is higher than in nondiabetic patients, both in the acute phase as on long-term follow-up [3], [4], [5]. Various pathophysiologic substrates may explain this clinical course. Diabetic patients have more extensive coronary artery disease [6], [7], a higher incidence of left ventricular failure [7], [8] and are more likely to develop fatal arrhythmias after myocardial infarction [9]. Strict glycemic control can prevent micro vascular complications [10], however an association with prevalence of macro vascular disease could not be found [1], [11]. The prevalence of diabetes in patients with myocardial infarction is high [12], [13]. Impaired glucose tolerance in patients with myocardial infarction has not been systematically recorded, although correlation between plasma glucose levels on admission in patients with myocardial infarction and mortality has been documented [14].
The aim of this study was to make an exploration of the extent of hyperglycaemia in an unselected patient population with myocardial infarction in daily clinical practice and to determine the relation between admission plasma glucose levels and major adverse cardiovascular events in the thrombolysis era.
Section snippets
Patients
From January 1st 1996 through January 1997, 352 consecutive patients were admitted to the CCU of our hospital with an acute myocardial infarction. All these patients were considered for inclusion in this study. For the purpose of this study, the late clinical outcome after an acute myocardial infarction was correlated to the glucose level of admission. Therefore 16 patients were excluded from the analysis because no admission glucose level was available (n=10), while six patients could not be
Characteristics
Characteristically the majority of the patients were males (71%) with a mean age of 68±11 years. Fifteen percent of these infarcted patients have a previous myocardial infarction, while 2 and 9% had undergone a coronary angioplasty or coronary bypass surgery, respectively. Twelve percent of these patients were previous diagnosed as diabetics, at admission 34% were treated with insulin (Table 1). Mean cholesterol and HDL-cholesterol were 5.7±1.1 and 1.0±0.3 mmol/l, respectively (data not shown).
Discussion
Our study in an unselected patient population has demonstrated that the prognostic importance of impaired glucose levels among patients admitted with myocardial infarction is high and that admission glucose level in these patients is independently correlated with late mortality. Overall the 1-year mortality rate is 19.3%, this is higher with increasing admission plasma glucose levels. The significance of hyperglycaemia among patients with myocardial infarction is not yet explained. Whether it
Conclusions
Increased admission plasma glucose levels among patients with myocardial infarction are significantly and independently correlated with mortality. Given its deleterious effects, the challenge for the future is to recognise these hyperglycemic patients in an early stage and to explore the possibilities of risk reducing. The decompensated metabolic glucose status, either due to catecholamine-induced effects or to an impaired insulin–glucose metabolism has a particular important effect on the
References (33)
- et al.
Metabolic control and prevalent cardiovascular disease in non-insulin dependent diabetes mellitus (NIDDM): The NIDDM patient outcomes research team
Am J Med
(1997) - et al.
Prevalence and risks of hyperglycaemia and undiagnosed diabetes in patients with acute myocardial infarction
Lancet
(1984) - et al.
Stress hyperglycaemia
Lancet
(1984) Hyperglycemia during physical stress
Am J Med
(1996)Hyperglycaemia and prognosis of acute myocardial infarction in patients without diabetes mellitus
Am J Cardiol
(1989)- et al.
Effects of acute hyperglycaemia on cardiac function: an echocardiographic study of monozygotic twins
Int. J Cardiol
(2000) - et al.
Relationship of glucose and insulin levels to the risk of myocardial infarction: a case-control study
J Am Coll Cardiol
(1999) Prognostic significance of diabetes in acute myocardial infarction. Are the differences linked to female gender?
Int J Cardiol
(1999)- et al.
Randomised trial of insulin–glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effects on mortality at 1 year
J Am Coll Cardiol
(1995) - et al.
Diabetes, other risk factors, and 12 year cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial
Diabetes Care
(1993)
Impact of diabetes on mortality after the first myocardial infarction
Diabetes Care
Mechanisms determining course and outcome of diabetic patients who have had acute myocardial infarction
Ann Intern Med.
Mortality and morbidity during a five year follow-up of diabetics with myocardial infarction
Acta Med Scand
Outcome of patients with diabetes mellitus and acute myocardial infarction treated with thrombolytic agents
J Am Coll Cardiol
Summary report from the consensus development conference on diagnosis of coronary heart disease in people with diabetes
Diabetes Care
Residual left ventricular pump function after acute myocardial infarction in NIDDM patients
Diabetes Care
Cited by (198)
Case Report: Transient Stress Hyperglycemia in the Patient With ST-Elevation Myocardial Infarction
2022, Journal for Nurse PractitionersCitation Excerpt :Multivariate regression analysis revealed independent predicators of stress hyperglycemia include family history of DM, body mass index >24 kg/m2, and cardiogenic shock on admission.6 Numerous studies have identified elevated glycemic levels during admission for AMI as an independent predictor of increased mortality risk, regardless of whether the patient has diabetes or not.7-9 In the 2012 Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) trial, researchers assessed the prognostic value of stress hyperglycemia among patients with STEMI treated with primary PCI.
Cerebral Metabolism and the Role of Glucose Control in Acute Traumatic Brain Injury
2016, Neurosurgery Clinics of North AmericaA systematic review and meta-regression of temporal trends in the excess mortality associated with diabetes mellitus after myocardial infarction
2016, International Journal of Cardiology2012 ACCF/AHA focused update incorporated into the ACCF/AHA 2007 guidelines for the management of patients with unstable angina/Non-ST-Elevation myocardial infarction: A report of the american college of cardiology Foundation/American Heart Association task force on practice guidelines
2013, Journal of the American College of Cardiology